Xylo- and arabinofuranosylthioguanine and related nucleosides derived from 2-acetamido-6-chloropurine.
D000081:Acetamides; D000085:Acetates / Q000138:chemical synthesis; D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis*; D001089:Arabinose / Q000138:chemical synthesis; D002277:Carcinoma / Q000188:drug therapy; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002460:Cell Line; D002713:Chlorine; D004987:Ethers / Q000138:chemical synthesis; D006151:Guanosine / Q000138:chemical synthesis; D006801:Humans; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009062:Mouth Neoplasms / Q000188:drug therapy; D009705:Nucleosides / Q000138:chemical synthesis* / Q000627:therapeutic use; D011687:Purines; D051381:Rats; D013329:Structure-Activity Relationship; D013449:Sulfonamides / Q000138:chemical synthesis; D013866:Thioguanine / Q000138:chemical synthesis / Q000627:therapeutic use; D014994:Xylose / Q000138:chemical synthesis
D000081:Acetamides; D000085:Acetates; D000970:Antineoplastic Agents; D004987:Ethers; D009705:Nucleosides; D011687:Purines; D013449:Sulfonamides; D006151:Guanosine; D002713:Chlorine; D014994:Xylose; D001089:Arabinose; D013866:Thioguanine